Mainz Biomed (MYNZ) Enterprise Value (2020 - 2025)
Mainz Biomed's Enterprise Value history spans 5 years, with the latest figure at -$6.2 million for Q4 2024.
- For Q4 2024, Enterprise Value rose 11.81% year-over-year to -$6.2 million; the TTM value through Dec 2024 reached -$6.2 million, up 11.81%, while the annual FY2024 figure was -$6.2 million, 11.81% up from the prior year.
- Enterprise Value for Q4 2024 was -$6.2 million at Mainz Biomed, up from -$7.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$122568.0 in Q4 2020 and bottomed at -$17.1 million in Q4 2022.
- The 5-year median for Enterprise Value is -$7.1 million (2023), against an average of -$7.9 million.
- The largest annual shift saw Enterprise Value crashed 7020.57% in 2021 before it surged 58.75% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$122568.0 in 2020, then plummeted by 7020.57% to -$8.7 million in 2021, then plummeted by 96.41% to -$17.1 million in 2022, then soared by 58.75% to -$7.1 million in 2023, then increased by 11.81% to -$6.2 million in 2024.
- Per Business Quant, the three most recent readings for MYNZ's Enterprise Value are -$6.2 million (Q4 2024), -$7.1 million (Q4 2023), and -$17.1 million (Q4 2022).